Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes

F. MacRÌ, D. Pitocco, E. Di Pasquo, S. Salvi, A. Rizzi, M. Di Leo, L. Tartaglione, E. Di Stasio, A. Lanzone, S. De Carolis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: Obesity and gestational diabetes mellitus (GDM) are rising worldwide. This study retrospectively evaluated the role of excessive gestational weight gain (eGWG) in women with GDM and different pre-pregnancy body mass indices (BMIs). PATIENTS AND METHODS: Optimal glycaemic control was defned as achieving glucose target thresholds in more than 80% of measurements. 283 women with GDM were categorized as underweight, normal weight, overweight or obese based on WHO's classifcation scheme. eGWG was defned as >18.0 kilograms for women who were underweight, >15.8 kilograms for those who were normal weight, >11.3 kilograms for those who were overweight and >9.0 kilograms for those who were obese. For the analysis, women were divided into two groups: normal and excessive GWG. The main outcomes measured were incidences of large/small for gestational age (LGA/SGA), macrosomia, preterm delivery, hypertensive disorders and caesarean sections (CS). RESULTS: Excessive GWG was associated with higher birth weight and percentile (p<0.001), and with a higher prevalence of LGA (p<0.001), macrosomia (p=0.002) and hypertensive disorders (p=0.036). No statistical differences were found for the week of delivery, or prevalence of CS and SGA. The multivariate analysis highlighted both pre-pregnant BMI and eGWG as independent risk factors for LGA and macrosomia. Women with a pre-pregnant BMI of at least 25 and eGWG have a 5.43-fold greater risk of developing LGA (p=0.005). CONCLUSIONS: When combined with an inadequate pre-pregnant BMI, eGWG acts as a "synergic risk factor" for a poor outcome. When obesity or GDM occur, an optimal GWG can guarantee a better pregnancy outcome.

Original languageEnglish
Pages (from-to)4403-4410
Number of pages8
JournalEuropean Review for Medical and Pharmacological Sciences
Volume22
Issue number14
Publication statusPublished - Jan 1 2018

Fingerprint

Gestational Diabetes
Pregnancy Outcome
Weight Gain
Body Mass Index
Thinness
Cesarean Section
Obesity
Weights and Measures
Birth Weight
Gestational Age
Multivariate Analysis
Glucose
Pregnancy
Incidence

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

MacRÌ, F., Pitocco, D., Di Pasquo, E., Salvi, S., Rizzi, A., Di Leo, M., ... De Carolis, S. (2018). Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes. European Review for Medical and Pharmacological Sciences, 22(14), 4403-4410.

Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes. / MacRÌ, F.; Pitocco, D.; Di Pasquo, E.; Salvi, S.; Rizzi, A.; Di Leo, M.; Tartaglione, L.; Di Stasio, E.; Lanzone, A.; De Carolis, S.

In: European Review for Medical and Pharmacological Sciences, Vol. 22, No. 14, 01.01.2018, p. 4403-4410.

Research output: Contribution to journalArticle

MacRÌ, F, Pitocco, D, Di Pasquo, E, Salvi, S, Rizzi, A, Di Leo, M, Tartaglione, L, Di Stasio, E, Lanzone, A & De Carolis, S 2018, 'Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes', European Review for Medical and Pharmacological Sciences, vol. 22, no. 14, pp. 4403-4410.
MacRÌ, F. ; Pitocco, D. ; Di Pasquo, E. ; Salvi, S. ; Rizzi, A. ; Di Leo, M. ; Tartaglione, L. ; Di Stasio, E. ; Lanzone, A. ; De Carolis, S. / Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes. In: European Review for Medical and Pharmacological Sciences. 2018 ; Vol. 22, No. 14. pp. 4403-4410.
@article{a813261816ea42b2bf3392dce316f843,
title = "Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes",
abstract = "OBJECTIVE: Obesity and gestational diabetes mellitus (GDM) are rising worldwide. This study retrospectively evaluated the role of excessive gestational weight gain (eGWG) in women with GDM and different pre-pregnancy body mass indices (BMIs). PATIENTS AND METHODS: Optimal glycaemic control was defned as achieving glucose target thresholds in more than 80{\%} of measurements. 283 women with GDM were categorized as underweight, normal weight, overweight or obese based on WHO's classifcation scheme. eGWG was defned as >18.0 kilograms for women who were underweight, >15.8 kilograms for those who were normal weight, >11.3 kilograms for those who were overweight and >9.0 kilograms for those who were obese. For the analysis, women were divided into two groups: normal and excessive GWG. The main outcomes measured were incidences of large/small for gestational age (LGA/SGA), macrosomia, preterm delivery, hypertensive disorders and caesarean sections (CS). RESULTS: Excessive GWG was associated with higher birth weight and percentile (p<0.001), and with a higher prevalence of LGA (p<0.001), macrosomia (p=0.002) and hypertensive disorders (p=0.036). No statistical differences were found for the week of delivery, or prevalence of CS and SGA. The multivariate analysis highlighted both pre-pregnant BMI and eGWG as independent risk factors for LGA and macrosomia. Women with a pre-pregnant BMI of at least 25 and eGWG have a 5.43-fold greater risk of developing LGA (p=0.005). CONCLUSIONS: When combined with an inadequate pre-pregnant BMI, eGWG acts as a {"}synergic risk factor{"} for a poor outcome. When obesity or GDM occur, an optimal GWG can guarantee a better pregnancy outcome.",
author = "F. MacR{\`I} and D. Pitocco and {Di Pasquo}, E. and S. Salvi and A. Rizzi and {Di Leo}, M. and L. Tartaglione and {Di Stasio}, E. and A. Lanzone and {De Carolis}, S.",
year = "2018",
month = "1",
day = "1",
language = "English",
volume = "22",
pages = "4403--4410",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "14",

}

TY - JOUR

T1 - Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes

AU - MacRÌ, F.

AU - Pitocco, D.

AU - Di Pasquo, E.

AU - Salvi, S.

AU - Rizzi, A.

AU - Di Leo, M.

AU - Tartaglione, L.

AU - Di Stasio, E.

AU - Lanzone, A.

AU - De Carolis, S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - OBJECTIVE: Obesity and gestational diabetes mellitus (GDM) are rising worldwide. This study retrospectively evaluated the role of excessive gestational weight gain (eGWG) in women with GDM and different pre-pregnancy body mass indices (BMIs). PATIENTS AND METHODS: Optimal glycaemic control was defned as achieving glucose target thresholds in more than 80% of measurements. 283 women with GDM were categorized as underweight, normal weight, overweight or obese based on WHO's classifcation scheme. eGWG was defned as >18.0 kilograms for women who were underweight, >15.8 kilograms for those who were normal weight, >11.3 kilograms for those who were overweight and >9.0 kilograms for those who were obese. For the analysis, women were divided into two groups: normal and excessive GWG. The main outcomes measured were incidences of large/small for gestational age (LGA/SGA), macrosomia, preterm delivery, hypertensive disorders and caesarean sections (CS). RESULTS: Excessive GWG was associated with higher birth weight and percentile (p<0.001), and with a higher prevalence of LGA (p<0.001), macrosomia (p=0.002) and hypertensive disorders (p=0.036). No statistical differences were found for the week of delivery, or prevalence of CS and SGA. The multivariate analysis highlighted both pre-pregnant BMI and eGWG as independent risk factors for LGA and macrosomia. Women with a pre-pregnant BMI of at least 25 and eGWG have a 5.43-fold greater risk of developing LGA (p=0.005). CONCLUSIONS: When combined with an inadequate pre-pregnant BMI, eGWG acts as a "synergic risk factor" for a poor outcome. When obesity or GDM occur, an optimal GWG can guarantee a better pregnancy outcome.

AB - OBJECTIVE: Obesity and gestational diabetes mellitus (GDM) are rising worldwide. This study retrospectively evaluated the role of excessive gestational weight gain (eGWG) in women with GDM and different pre-pregnancy body mass indices (BMIs). PATIENTS AND METHODS: Optimal glycaemic control was defned as achieving glucose target thresholds in more than 80% of measurements. 283 women with GDM were categorized as underweight, normal weight, overweight or obese based on WHO's classifcation scheme. eGWG was defned as >18.0 kilograms for women who were underweight, >15.8 kilograms for those who were normal weight, >11.3 kilograms for those who were overweight and >9.0 kilograms for those who were obese. For the analysis, women were divided into two groups: normal and excessive GWG. The main outcomes measured were incidences of large/small for gestational age (LGA/SGA), macrosomia, preterm delivery, hypertensive disorders and caesarean sections (CS). RESULTS: Excessive GWG was associated with higher birth weight and percentile (p<0.001), and with a higher prevalence of LGA (p<0.001), macrosomia (p=0.002) and hypertensive disorders (p=0.036). No statistical differences were found for the week of delivery, or prevalence of CS and SGA. The multivariate analysis highlighted both pre-pregnant BMI and eGWG as independent risk factors for LGA and macrosomia. Women with a pre-pregnant BMI of at least 25 and eGWG have a 5.43-fold greater risk of developing LGA (p=0.005). CONCLUSIONS: When combined with an inadequate pre-pregnant BMI, eGWG acts as a "synergic risk factor" for a poor outcome. When obesity or GDM occur, an optimal GWG can guarantee a better pregnancy outcome.

UR - http://www.scopus.com/inward/record.url?scp=85051354699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051354699&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85051354699

VL - 22

SP - 4403

EP - 4410

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 14

ER -